Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Arkuda Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Arkuda Therapeutics

Arkuda Therapeutics

Arkuda Therapeutics: Pioneering neurodegenerative disease treatments through innovative biotechnology.

HQ
Watertown, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Arkuda Therapeutics is a biotechnology company dedicated to developing innovative medicines aimed at altering the progression of neurodegenerative diseases. Leveraging their specialized expertise in progranulin and lysosomal biology, Arkuda focuses on creating treatments for conditions such as Alzheimer's Disease, Parkinson's Disease, and frontotemporal dementia (FTD). Their mission is to bring new therapeutic options to those affected by these debilitating diseases, ultimately aiming to improve patients' lives.

Arkuda Therapeutics has made significant strides in the field of neurodegeneration, utilizing cutting-edge research and insights into lysosomal biology. Their pioneering approach has positioned them as a key player in the development of novel treatments that could potentially change the course of neurodegenerative diseases. The company's impact is marked by its commitment to translating scientific discoveries into practical therapies that offer hope and improved outcomes for patients worldwide.

Arkuda Therapeutics - Similar Companies

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Denali Therapeutics logo

Denali Therapeutics

Endlyz Therapeutics logo

Endlyz Therapeutics

Aprinoia Therapeutics logo

Aprinoia Therapeutics

aprinoia.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Libra Therapeutics logo

Libra Therapeutics

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Amylyx Pharmaceuticals logo

Amylyx Pharmaceuticals

amylyx.com

Neuraly logo

Neuraly

neuralymed.com

Asha Therapeutics logo

Asha Therapeutics

Adrx logo

Adrx

adrxpharma.com

Samsara Therapeutics logo

Samsara Therapeutics

Aztherapies logo

Aztherapies

Link Medicine logo

Link Medicine

linksciences.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

Arkuda Therapeutics - Quick Facts

Who are Arkuda Therapeutics' competitors?

Companies similar to Arkuda Therapeutics include Lysosomal Therapeutics, Denali Therapeutics, Endlyz Therapeutics and Aprinoia Therapeutics.

When was Arkuda Therapeutics founded?

Arkuda Therapeutics was founded in 2018.

Where is Arkuda Therapeutics' headquarters located?

Arkuda Therapeutics' headquarters is located in Watertown, MA, US.

When was Arkuda Therapeutics' last funding round?

Arkuda Therapeutics' most recent funding round was for $64M (USD) in February 2022.

How much has Arkuda Therapeutics raised to-date?

As of Feb 10, 2022, Arkuda Therapeutics has raised a total of $108M (USD).

How many employees does Arkuda Therapeutics have?

Arkuda Therapeutics has 30 employees as of Feb 4, 2024.

Arkuda Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified